Rentokil Initial PLC
RTO: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ^Vh | LOCK|!z?x | LOCK|xKxX$Y |
Rentokil Earnings: Acceleration of Organic Growth and Lead Generation Drives Strong Performance
Rentokil's North American business experienced organic growth of 1.4% in the second quarter, up from both the same quarter last year and the first quarter of 2025, driven by an increase in leads and customer retention. Shares are up 10% in early trading.
